Literature DB >> 21899122

[Clinical study of forty-two patients who underwent resection for pulmonary adenosquamous carcinoma].

Yasumasa Shundo1, Tsuyoshi Takahashi, Toru Itaya, Hiroshi Neyatani, Hisao Sugimura, Yusuke Kita, Hiroshi Nogimura, Ryo Kobayashi, Kazuya Suzuki, Kei Shimizu, Kazuhito Funai, Norihiko Shiiya.   

Abstract

Pulmonary adenosquamous carcinoma is a rare malignant tumor as defined by the Japan Lung Cancer Society Classification. At our institution, of the 1,023 patients who underwent resection for primary lung cancer, 42 (4.0%) had adenosquamous carcinoma. Here, we present the clinical features of this malignant tumor. The male : female ratio was low. Many tumors were located peripherally, and the positive rate for carcinoembryonic antigen (CEA) was 54.8%; these clinical findings were similar to those of adenocarcinoma. On the other hand, many tumors had relatively large diameter, and most of the patients were heavy smokers; these findings were consistent with those of squamous cell carcinoma. Hence, the cases of adenosquamous carcinoma had the characteristics of both adenocarcinoma and squamous cell carcinoma. The prognosis of patients with adenosquamous carcinoma was poorer than those of patients with adenocarcinoma and those with squamous cell carcinoma, irrespective of whether it was stages I or II. Adenosquamous carcinoma is characterized by a highly aggressive biological behavior and a high rate of early metastasis. Therefore, even if the diagnosis is made at an early phase, an aggressive approach, including adjuvant chemotherapy, might be necessary for adenosquamous carcinoma.

Entities:  

Mesh:

Year:  2011        PMID: 21899122

Source DB:  PubMed          Journal:  Kyobu Geka        ISSN: 0021-5252


  4 in total

1.  [Clinicopathologic Features and Prognostic Implications in 72 Cases 
with Lung Adenosquamous Carcinoma].

Authors:  Xi Wu; Junling Li; Shulan Chen; Lei Yu; Boyan Yang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2016-10-20

Review 2.  Research progress of the clinicopathologic features of lung adenosquamous carcinoma.

Authors:  Jing Wang; Yanling Wang; Mengting Tong; Hongming Pan; Da Li
Journal:  Onco Targets Ther       Date:  2018-10-16       Impact factor: 4.147

3.  c-FOS drives reversible basal to squamous cell carcinoma transition.

Authors:  François Kuonen; Nancy Yanzhe Li; Daniel Haensel; Tiffany Patel; Sadhana Gaddam; Laura Yerly; Kerri Rieger; Sumaira Aasi; Anthony E Oro
Journal:  Cell Rep       Date:  2021-10-05       Impact factor: 9.423

4.  Construction and validation of a novel prognostic model for lung squamous cell cancer based on N6-methyladenosine-related genes.

Authors:  Erna Jia; Na Ren; Boyin Zhang; Jinru Xue; Bo Guo; Zhi Cui
Journal:  World J Surg Oncol       Date:  2022-02-27       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.